Loading company details...
Beta
Latest Form 4 (May 26, 2023): TAKEDA PHARMACEUTICAL CO LTD (Insider): Other (see footnotes) of 1,000,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 26, 2023 | TAKEDA PHARMACEUTICAL CO LTD | Other (see footnotes) | 1,000,000 | n/a |
| Feb 1, 2023 | Deepika Pakianathan | Sale | 120,161 | $46.4K |
| Jan 25, 2023 | Eric Sjogren, SR. VP, DRUG DISCOVERY | Tax Withholding | 279 | $124.46 |
| Jan 25, 2023 | Emil Kuriakose, CHIEF MEDICAL OFFICER | Tax Withholding | 79 | $35.24 |
| Jan 25, 2023 | Susan Molineaux, PRESIDENT & CEO | Tax Withholding | 526 | $234.65 |
| Jan 25, 2023 | Stephanie Wong, CHIEF FINANCIAL OFFICER & SECRETARY | Tax Withholding | 317 | $141.41 |
| Jan 25, 2023 | Christopher Molineaux, SR. VP, DEVELOPMENT | Tax Withholding | 217 | $96.80 |
| Jul 6, 2022 | TAKEDA PHARMACEUTICAL CO LTD | Other (see footnotes) | 1,000,000 | n/a |
| Jun 3, 2022 | Suzy Jones | Grant/Award | 20,000 | n/a |
| Jun 3, 2022 | Deepika Pakianathan | Grant/Award | 20,000 | n/a |